Boehringer Ingelheim Pharmaceuticals

Prices of 565 vital medicines reduced

“Our adoption of the decision to approve the reduction of the prices of the pharmaceutical drugs is a practical step towards providing comprehensive health care to all members of our society. This is part of the ministry’s vision and mission to put health, disease prevention and treatment as our national priorities,” UAE Health Minister Dr Hanif Hassan said at a Press conference on Monday. After working in the field for the past 12 years, Mohanan noted the relatively costly nature of medicines in the UAE. “Compared to other countries, medicines in the UAE are still on the higher side, but that is because almost all drugs are imported from all over the world. With the Ministry of Health tying up with international drug companies, prices can steadily be decreased with time, which is good for patients who don’t have insurance. An average type-2 diabetes patient can spend more than Dh500 a month on medication alone, so these kinds of price reductions can really make a difference,” he said. According to Mohanan, the most popular prescription drugs include Lipitor by Pfizer aimed at patients with heart disease and high cholesterol levels; Xanax by Pfizer, used to treat moderate to severe anxiety disorders and panic attacks; and Januvia by Merck Sharp & Dohme, used in conjunction with exercise and dietary restrictions to lower blood sugar levels in adults with type-2 diabetes. All three of the top-sellers will sell cheaper from July. From September, 103 drugs under GlaxoSmithKline, will be available at reduced prices for the general public. Other firms supporting price reductions include Alcon Pharmaceuticals Ltd, Astrazeneca, Bayer Schering, Boehringer Ingelheim, Bristol-Myers Squibb, Chauvin Pharmaceuticals Ltd., Eli Lilly, Ferring Pharmaceuticals, H. Lundbeck A/S, Hoffmann-La Roche Ltd., Janssen-Cilag, Les Laboratories Servier, Merck Serono, Novartis Pharma AG, Sanofi Aventis, and Valeant Pharmaceuticals. Once the directive by the Ministry of Health is announced to all pharmacies and hospitals, price stickers and inventory lists will need to be revised. “We will need to wait for official instructions on how to treat old stock ordered before the directive. Some pharmacies may choose to absorb 20 per cent of the price until new shipments come in, but it depends on a lot of factors and we cannot be sure,” Mohanan added.

Boehringer Ingelheim and Ashoka announce a global partnership for ...

Boehringer Ingelheim and Ashoka will launch a three-year global initiative to improve health in communities around the world.The "Making More Health" initiative will promote healthy individuals, families and communities by identifying and supporting the most promising solutions to challenge health problems.

The partnership includes support for a series of programs aimed at identifying innovative health solutions, including the election of 50 leading social entrepreneurs (elected as "Ashoka Fellows") whose ideas are driving cutting-edge systemic solutions in the field of health. In addition, two web-based changemakers competitions will open an invitation to the public to submit new ideas on how to improve health in underserved communities. "Making More Health" will also focus on the next generation of changemakers through a youth venture program to engage young people in designing health solutions for their communities.

Boehringer Ingelheim will support "Making More Health" by engaging its 42,000 employees worldwide in various capacities to help spread an understanding and appreciation of social entrepreneurship and health innovation within their own communities.

Boehringer Ingelheim will support "Making More Health" by engaging its 42,000 employees worldwide in various capacities to help spread an understanding and appreciation of social entrepreneurship and health innovation within their own communities.

"Making More Health brings together two organizations committed to finding innovative people and ideas to help shape the future of the health sector," said Professor Dr Andreas Barner, chairman of the board of managing directors at Boehringer Ingelheim. "Through this partnership we will bring forth meaningful and sustainable solutions that can achieve individual and family well-being in communities around the globe."

Ashoka's Chair, Bill Drayton, commented: "Some parts of how the world deals with health are highly creative, most especially the development of new pharmaceuticals, an area where Boehringer Ingelheim has made contribution after contribution for 125 years. Much of the rest of the system, however, has fallen way behind the need. The Making More Health partnership creates a global and business/social alliance led by top entrepreneurs and open to all that we believe will bring big changes to the entire system.

Birmingham movement disorders course 2006, Jury's Inn Hotel, Birmingham 15th to 17th March, 2006

Kenya National Assembly Official Record (Hansard)

He insists that Boehringer Ingelheim Pharmaceuticals attached some conditions. ... As far as I am concerned, Boehringer Ingelheim Pharmaceuticals offered ...

Kenya National Assembly Official Record (Hansard)

He insists that Boehringer Ingelheim Pharmaceuticals attached some conditions. ... As far as I am concerned, Boehringer Ingelheim Pharmaceuticals offered ...

A Special Report on Gene Therapy

Research in gene therapy is carried out at Boehringer Ingelheim Austria GmbH/ Austria and Boehringer Ingelheim Pharmaceuticals Inc./ USA Technologies ...

Vault career guide to pharmaceutical sales & marketing

Appendix Boeringer Ingelheim Boehringer Ingelheim Pharmaceuticals, Inc. 900 Ridgebury Road/PO Box 368 Ridgefield, CT 06877 Tel: 203.798.9988 Internet: ...